{"id":917419,"date":"2026-10-05T21:30:10","date_gmt":"2026-10-05T21:30:10","guid":{"rendered":"https:\/\/www.newsbeep.com\/au\/917419\/"},"modified":"2026-10-05T21:30:10","modified_gmt":"2026-10-05T21:30:10","slug":"higher-ozempic-dose-vs-mounjaro-which-is-better-for-heart-health","status":"publish","type":"post","link":"https:\/\/www.newsbeep.com\/au\/917419\/","title":{"rendered":"Higher Ozempic Dose vs. Mounjaro: Which is Better For Heart Health?"},"content":{"rendered":"<p><img decoding=\"async\" loading=\"eager\" src=\"https:\/\/www.newsbeep.com\/au\/wp-content\/uploads\/2026\/10\/getty_2286508296_header_1296x728.jpg\" alt=\"Male holding a GLP-1 injection pen\" class=\"css-bt1qz0\"\/><a class=\"icon-hl-pinterest css-foz1gx\" target=\"_blank\" rel=\"noopener noreferrer nofollow\" data-event=\"Any Page|Image Pinterest Click|Icon Clicked\" data-element-event=\"OPEN|CONTENTBLOCK|Any Page|Article Body|BUTTON|Image Widget Pinterest Click|\" href=\"https:\/\/www.pinterest.com\/pin\/create\/button\/?url=https%3A%2F%2Fwww.healthline.com%2Fhealth-news%2Fincrease-ozempic-dose-lower-heart-events-mounjaro&amp;media=https%3A%2F%2Fmedia.post.rvohealth.io%2Fwp-content%2Fuploads%2F2026%2F10%2Fgetty_2286508296_header_1296x728.jpg&amp;description=Higher%20Ozempic%20Dose%20vs.%20Mounjaro%3A%20Which%20is%20Better%20For%20Heart%20Health%3F\" title=\"Share on Pinterest\" data-pin-custom=\"true\" data-share-url=\"https:\/\/www.newsbeep.com\/au\/wp-content\/uploads\/2026\/10\/getty_2286508296_header_1296x728.jpg\">Share on Pinterest<\/a>Recent research suggests that increasing your Ozempic dose may offer greater heart protection than switching to Mounjaro. Eva Kongshavn \u00b7 Moment\/GettyA real-world study found that people with type 2 diabetes who increased their Ozempic dose rather than switching to Mounjaro had a lower risk of major adverse cardiovascular events (MACE).Those who increased their Ozempic dose to 2 mg had a 6% lower risk of MACE than those who switched to Mounjaro.Because the study was observational, it showed an association and does not prove that increasing the Ozempic dose caused the lower cardiovascular risk.<\/p>\n<p>It is important to keep in mind that this was a retrospective, observational study that showed an association, not causation. <\/p>\n<p>More research is needed to fully compare the cardiovascular benefits of semaglutide versus tirzepatide.<\/p>\n<p>The COMPETE SWITCH Cardiovascular (CV) analysis used Komodo Health\u2019s Healthcare Map, a large US healthcare claims database with linked laboratory results, to examine real-world data from 636,525 adults with type 2 diabetes.<\/p>\n<p>The analysis focused on 185,705 people who increased their semaglutide dose and 23,104 who switched to tirzepatide.<\/p>\n<p>All participants included in the analysis were already receiving 1 mg of semaglutide (Ozempic) weekly.<\/p>\n<p>67.2% remained on 1 mg of Ozempic29.2% escalated to 2 mg of Ozempic3.6% switched to tirzepatide (Mounjaro) within 1 year of starting the 1 mg Ozempic dose<\/p>\n<p>At the 720-day follow-up: <\/p>\n<p>57.4% remained on the 1 mg of Ozempic36.9% escalated to 2 mg of Ozempic5.7% switched to Mounjaro<\/p>\n<p>The researchers found that people who increased their Ozempic dose to 2 mg had a 6% lower risk of MACE \u2014 including all-cause death, myocardial infarction (<a href=\"https:\/\/www.healthline.com\/health\/heart-attack\" class=\"content-link css-kxhged\" rel=\"nofollow noopener\" target=\"_blank\">heart attack)<\/a>, and <a href=\"https:\/\/www.healthline.com\/health\/stroke\" class=\"content-link css-kxhged\" rel=\"nofollow noopener\" target=\"_blank\">stroke<\/a> \u2014 compared with those who switched to Mounjaro at doses up to 15 mg.<\/p>\n<p>\u201cThis is an interesting study, but the findings may partly reflect medication adherence. When patients switch medications, it can take time to adjust the dose and find the right treatment level, which may temporarily affect how well their condition is controlled,\u201d said <a href=\"https:\/\/www.memorialcare.org\/providers\/mir-b-ali\" target=\"_blank\" rel=\"noopener noreferrer nofollow\" class=\"content-link css-kxhged\">Mir Ali<\/a>, MD, medical director of MemorialCare Surgical Weight Loss Center at Orange Coast Medical Center in Fountain Valley, CA, who wasn\u2019t involved in the study. <\/p>\n<p>He also noted that the study did not determine what might explain the difference in cardiovascular risk.<\/p>\n<p>\u201cIt may be related to a combination of weight loss and direct effects on hormones involved in metabolism and appetite regulation,\u201d Ali said. <\/p>\n<p>Semaglutide and tirzepatide are both GLP-1 medications. <a href=\"https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2023\/209637s020s021lbl.pdf\" target=\"_blank\" rel=\"noopener noreferrer nofollow\" class=\"content-link css-kxhged\">Ozempic<\/a> (semaglutide) and <a href=\"https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2022\/215866s000lbl.pdf\" target=\"_blank\" rel=\"noopener noreferrer nofollow\" class=\"content-link css-kxhged\">Mounjaro<\/a> (tirzepatide) are approved to help manage type 2 diabetes, while each medication also has a different brand approved for weight loss.<\/p>\n<p>\u201cSemaglutide and tirzepatide work in a similar way. While semaglutide is a direct <a href=\"https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK603723\/\" target=\"_blank\" rel=\"noopener noreferrer nofollow\" class=\"content-link css-kxhged\">GLP-1 receptor agonist<\/a>, tirzepatide is a <a href=\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC9268041\/\" target=\"_blank\" rel=\"noopener noreferrer nofollow\" class=\"content-link css-kxhged\">dual agonist<\/a> of both the GIP and GLP-1 receptors,\u201d <a href=\"https:\/\/manhattancardiology.com\/team\/dr-amit-blumfield\/\" target=\"_blank\" rel=\"noopener noreferrer nofollow\" class=\"content-link css-kxhged\">Amit Blumfield<\/a>, MD, with Manhattan Cardiology in NYC, who wasn\u2019t involved in the study, told Healthline. <\/p>\n<p>\u201cBecause they work through somewhat different pathways, they can have different effects in individual patients,\u201d added Ali. <\/p>\n<p>While both semaglutide (Ozemipc) and tirzepatide (Mounjaro) work in similar ways, you may find that you tolerate one better than the other. <\/p>\n<p>Ali noted that you should discuss any potential benefits and drawbacks with your healthcare professional. <\/p>\n<p>\u201cI would only recommend switching medications if there is an issue with tolerance of one or the other. If one medication is well-tolerated at increasingly higher doses and is effective in the desired weight-loss and blood sugar management, I wouldn\u2019t necessarily switch,\u201d added Blumfield. <\/p>\n<p>nausea and vomitingdiarrhea constipationreactions at the injection site<\/p>\n<p>These side effects are generally mild and may lessen over time. However, if side effects become difficult to tolerate, you should speak with your healthcare professional.<\/p>\n<p>\u201cGLP-1 medications can be highly effective for managing diabetes and promoting weight loss, but there is no one-size-fits-all treatment. The best medication depends on an individual\u2019s health needs, goals, response to treatment, and potential side effects,\u201d said Ali.<\/p>\n","protected":false},"excerpt":{"rendered":"Share on PinterestRecent research suggests that increasing your Ozempic dose may offer greater heart protection than switching to&hellip;\n","protected":false},"author":2,"featured_media":917420,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[33],"tags":[64,63,137,490],"class_list":["post-917419","post","type-post","status-publish","format-standard","has-post-thumbnail","category-medication","tag-au","tag-australia","tag-health","tag-medication"],"_links":{"self":[{"href":"https:\/\/www.newsbeep.com\/au\/wp-json\/wp\/v2\/posts\/917419","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.newsbeep.com\/au\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.newsbeep.com\/au\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/au\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/au\/wp-json\/wp\/v2\/comments?post=917419"}],"version-history":[{"count":0,"href":"https:\/\/www.newsbeep.com\/au\/wp-json\/wp\/v2\/posts\/917419\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/au\/wp-json\/wp\/v2\/media\/917420"}],"wp:attachment":[{"href":"https:\/\/www.newsbeep.com\/au\/wp-json\/wp\/v2\/media?parent=917419"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.newsbeep.com\/au\/wp-json\/wp\/v2\/categories?post=917419"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.newsbeep.com\/au\/wp-json\/wp\/v2\/tags?post=917419"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}